What Researchers Did
This review summarized the critical role of vascular endothelium and glycocalyx in cardiovascular health and explored the potential therapeutic benefits of hyperbaric oxygen therapy (HBOT) for cardiovascular risk factors and disease.
What They Found
Researchers found that endothelial dysfunction is a key contributor to cardiovascular disease, influenced by factors like diabetes, chronic kidney disease, and obesity. The review highlighted that HBOT may offer therapeutic benefits by promoting angiogenesis, showing antimicrobial and immunomodulatory effects, enhancing antioxidant defenses, and stimulating stem cell activity, thereby impacting cardiac function and plaque stability.
What This Means for Canadian Patients
Hyperbaric oxygen therapy could potentially offer a novel approach for Canadian patients to manage cardiovascular risk factors and improve overall heart health. Further research may determine its practical application in preventing and treating conditions like atherosclerosis and heart failure.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a review, this study's findings are based on existing literature and highlight the need for more primary clinical trials to confirm the efficacy of HBOT in cardiovascular disease.